Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 07, 2025
Arcinova, a Quotient Sciences company, and UK-based Contract Research Development and Manufacturing Organization (CRDMO), announced the appointment of Dr. Christian Dowdeswell as new Managing Director.
read more
Wednesday, April 18, 2018
Arcinova has announced the award of a £1.5 million Innovate UK grant for the development of new flexible modular manufacturing technologies.
read more
Monday, February 10, 2020
Through its fully automated drug discovery platform, Arctoris enables researchers and biotechnological entrepreneurs to design and remotely execute advanced cell-based, molecular biology and biochemical assays.
read more
Wednesday, November 13, 2019
Arctoris announced the appointment of Professor John Mattick AO FAA FTSE FAHMS FRSN HonFRCPA GAICD as a Member of the Board of Directors, and Daniel Thomas PhD LCGI as Head of Discovery Biology.
read more
Arctoris has established a broad range of remotely accessible COVID-19 assays.
read more
Wednesday, December 11, 2019
Arctoris has opened its new global headquarters and state-of-the-art R&D facility in Oxford, UK.
read more
Friday, September 18, 2020
Arctoris has signed a Memorandum of Understanding with listed Korean company Syntekabio to collaborate on drug discovery efforts.
read more
Arcturus and Catalent have announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate intended to protect against the SARS-CoV-2 coronavirus.
read more
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, has announced that Paul Korner, MD, MBA, joined the Company in a newly created position as Executive Vice President and Chief Medical ...
read more
Tuesday, November 28, 2017
Ardelyx and Kyowa Hakko Kirin announced they have entered into a license agreement that provides Kyowa Hakko Kirin with exclusive rights to develop and commercialize tenapanor.
read more
Ardena has acquired ChemConnection, a contract manufacturer of novel APIs and nanomedicines.
read more
Wednesday, September 08, 2021
Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO), has announced that it has acquired Idifarma, a leading Contract Manufacturer of niche and highly potent generic and innovative drugs.
read more
Ardena has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.
read more
Contract development manufacturer of nanomedicines, Ardena, has joined forces with mRNA and LNP technology specialists RiboPro to form a new strategic commercial alliance aimed at delivering improvements
read more
Thursday, October 20, 2022
Ardena, a fully integrated Contract Development and Manufacturing Organization (CDMO) assisting biopharma companies with services spanning across the development life cycle, is investing into almost trebling the size of its Swedish facility as part ...
read more